Alvotech Sees AbbVie’s Humira Trade Secrets Case Thrown Out In US

AbbVie Had Accused Alvotech Employee Of Stealing ‘Useful’ Information

 
• By Dean Rudge

One part of a multi-pronged attack launched by AbbVie against Alvotech over the company’s proposed Humira (adalimumab) biosimilar has fallen, with a US district court stating that AbbVie’s US trade secrets lawsuit should be dismissed because it lacks a form of jurisdiction.

Trade Secrets Padlock Wooden People
The litigation revolved around Humira trade secrets • Source: Alamy

A US lawsuit accusing Alvotech of illegally obtaining AbbVie’s trade secrets related to the originator’s Humira (adalimumab) brand for use in developing its own biosimilar rival has been dismissed by a US district court for lack of personal jurisdiction.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Biosimilars

More from Products